The regulatory role of microRNAs in angiogenesis-related diseases.

The regulatory role of microRNAs in angiogenesis-related diseases.
复制标题

DOI:
10.1111/jcmm.13700
复制
发表时间:
2018-10
影响因子:
5.3
通讯作者:
Li XQ
Li XQ
中科院分区:
医学2区
文献类型:
--
作者:
Sun LL;Li WD;Lei FR;Li XQ

文献摘要

参考文献

被引文献

相似文献

MicroRNA (miRNA) 是一种小型非编码 RNA,可通过目标 mRNA 的降解或翻译抑制在转录后水平调节基因表达。它们通过调节血管生成相关细胞的增殖、分化、凋亡、迁移和管形成等,在血管生成中发挥着不可替代的作用,是众多生理和病理过程,特别是血管疾病的发生和发展所不可缺少的。 miRNA与血管生成的调节失衡可能导致癌症、心血管疾病、动脉瘤、川崎病、主动脉夹层、静脉血栓和糖尿病微血管并发症等多种疾病。因此,探索 miRNA 在血管生成中的重要作用非常重要,这可能有助于发现新的、有效的血管疾病治疗策略。本综述重点关注 miRNA 与血管生成之间的相互作用,以及基于 miRNA 的生物标志物在血管生成相关疾病的诊断、治疗和预后中的作用,为人们对 miRNA 靶向血管生成的临床价值的认识提供了最新的认识。
MicroRNAs (miRNAs) are small non‐coding RNAs that regulate gene expression at a post‐transcriptional level via either the degradation or translational repression of a target mRNA. They play an irreplaceable role in angiogenesis by regulating the proliferation, differentiation, apoptosis, migration and tube formation of angiogenesis‐related cells, which are indispensable for multitudinous physiological and pathological processes, especially for the occurrence and development of vascular diseases. Imbalance between the regulation of miRNAs and angiogenesis may cause many diseases such as cancer, cardiovascular disease, aneurysm, Kawasaki disease, aortic dissection, phlebothrombosis and diabetic microvascular complication. Therefore, it is important to explore the essential role of miRNAs in angiogenesis, which might help to uncover new and effective therapeutic strategies for vascular diseases. This review focuses on the interactions between miRNAs and angiogenesis, and miRNA‐based biomarkers in the diagnosis, treatment and prognosis of angiogenesis‐related diseases, providing an update on the understanding of the clinical value of miRNAs in targeting angiogenesis.
狼疮性肾炎和糖尿病肾病中新型尿液 MicroRNA 生物标志物的鉴定、确认和复制。
DOI: 10.1373/clinchem.2017.274175
发表时间: 2017-09
期刊: Clinical chemistry
影响因子: 9.3
作者:
Cardenas-Gonzalez M;Srivastava A;Pavkovic M;Bijol V;Rennke HG;Stillman IE;Zhang X;Parikh S;Rovin BH;Afkarian M;de Boer IH;Himmelfarb J;Waikar SS;Vaidya VS
通讯作者: Vaidya VS
DOI: 10.1155/2015/354517
发表时间: 2015
影响因子: --
作者:
Chistiakov DA;Sobenin IA;Orekhov AN;Bobryshev YV
通讯作者: Bobryshev YV
DOI: 10.1007/s00246-016-1487-3
发表时间: 2017-01-01
影响因子: 1.6
作者:
Chen, Weidan;Li, Shoujun
通讯作者: Li, Shoujun
DOI: 10.1371/journal.pone.0050165
发表时间: 2012
期刊: PloS one
影响因子: 3.7
作者:
Bao B;Ali S;Ahmad A;Azmi AS;Li Y;Banerjee S;Kong D;Sethi S;Aboukameel A;Padhye SB;Sarkar FH
通讯作者: Sarkar FH
DOI: 10.1161/circulationaha.117.028034
发表时间: 2017-12-19
期刊: Circulation
影响因子: 37.8
作者:
Caruso P;Dunmore BJ;Schlosser K;Schoors S;Dos Santos C;Perez-Iratxeta C;Lavoie JR;Zhang H;Long L;Flockton AR;Frid MG;Upton PD;D'Alessandro A;Hadinnapola C;Kiskin FN;Taha M;Hurst LA;Ormiston ML;Hata A;Stenmark KR;Carmeliet P;Stewart DJ;Morrell NW
通讯作者: Morrell NW